Central nervous system glial niche

The central nervous system (CNS) glial niche is a specialized multicellular microenvironment consisting of astrocytes, microglia, oligodendrocytes, and the extracellular matrix (Source: PubMed, PMID: 30236530). This niche plays a fundamental role in maintaining CNS homeostasis by providing metabolic support to neurons, regulating the blood-brain barrier, and managing synaptic connectivity through pruning (Source: Nature Reviews Neuroscience, 2018). In pathological conditions such as Alzheimer's disease, multiple sclerosis, and stroke, the glial niche becomes dysfunctional, often characterized by chronic neuroinflammation and the loss of neurosupportive functions (Source: Science, 2021). While the niche is not a single molecular target like a receptor or enzyme, it is a critical therapeutic compartment; drugs targeting its components aim to resolve inflammation and promote tissue repair (Source: Frontiers in Cellular Neuroscience, 2020). Consequently, the glial niche is a focal point for developing disease-modifying therapies in neurology.

Other names

CNS glial microenvironmentGlial cell nicheNeurogenic nicheGlial-vascular niche

Pharmacological modulation of the glial niche typically involves the activation or inhibition of specific receptors on astrocytes, microglia, or oligodendrocytes to shift the microenvironment from a neurotoxic/pro-inflammatory state to a neuroprotective/pro-repair state (Source: Nature Reviews Drug Discovery, 2017).